Inflammatory markers and physical performance among nonagenarians

Journals of Gerontology - Series A Biological Sciences and Medical Sciences

Volumn 65 A, Issue 6, 2010, Pages 658-663

  Tiainen, Kristina ^a   Hurme, Mikko ^b,c   Hervonen, Antti ^a   Luukkaala, Tiina ^a,d   Jylhä, Marja ^a  

^a UNIVERSITY OF TAMPERE   (Finland)

^b UNIVERSITY OF TAMPERE MEDICAL SCHOOL   (Finland)

^c TAMPERE UNIVERSITY HOSPITAL   (Finland)

^d PIRKANMAA HOSPITAL DISTRICT   (Finland)

Author keywords

Aging; Disability; Inflammation; Muscle strength; Oldest old

Indexed keywords

BIOLOGICAL MARKER; C REACTIVE PROTEIN; INTERLEUKIN 1 RECEPTOR BLOCKING AGENT; INTERLEUKIN 6;

AGED; ARTICLE; BLOOD; DAILY LIFE ACTIVITY; FEMALE; HAND STRENGTH; HUMAN; INFLAMMATION; MALE; METABOLISM; PROSPECTIVE STUDY;

ACTIVITIES OF DAILY LIVING; AGED, 80 AND OVER; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; FEMALE; HAND STRENGTH; HUMANS; INFLAMMATION; INTERLEUKIN 1 RECEPTOR ANTAGONIST PROTEIN; INTERLEUKIN-6; MALE; PROSPECTIVE STUDIES;

EID: 77952988388     PISSN: 10795006     EISSN: 1758535X     Source Type: Journal    
DOI: 10.1093/gerona/glq056     Document Type: Article

References (36)

1. Bean JF, Leveille SG, Kiely DK, Bandinelli S, Guralnik JM, Ferrucci L. A comparison of leg power and leg strength within the incHianti study: which infuences mobility more? J Gerontol A Biol Sci Med Sci. 2003;58:728-733.
2. Lauretani F, Russo CR, Bandinelli S, et al. age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia. J Appl Physiol. 2003;95:1851-1860.
3. Ferrucci L, Corsi A, Lauretani F, et al. the origins of age-related proinfammatory state. Blood. 2005;105:2294-2299.
4. Krabbe KS, Pedersen M, Bruunsgaard H. infammatory mediators in the elderly. Exp Gerontol. 2004;39:687-699.
5. Ershler WB, Keller ET. age-associated increased interleukin-6 gene expressioN, late-life diseaseS, and frailty. Annu Rev Med. 2000;51: 245-270.
6. Dinarello CA. Biologic basis for interleukin-1 in disease. Blood. 1996;87:2095-2147.
7. Apte RN, Voronov E. is interleukin-1 a good or bad 'guy' in tumor immunobiology and immunotherapy? Immunol Rev. 2008;222: 222-241.
8. Barksby HE, Lea SR, Preshaw PM, Taylor JJ. the expanding family of interleukin-1 cytokines and their role in destructive infammatory disorders. Clin Exp Immunol. 2007;149:217-225.
9. Arend WP. the balance between il-1 and il-1Ra in disease. Cytokine Growth Factor Rev. 2002;13:323-340.
10. Grimble RF. infammatory response in the elderly. Curr Opin Clin Nutr Metab Care. 2003;6:21-29.
11. Ballou SP, Lozanski FB, Hodder S, et al. Quantitative and qualitative alterations of acute-phase proteins in healthy elderly persons. Age Ageing. 1996;25:224-230.
12. Lehtimaki T, Ojala P, Rontu R, et al. interleukin-6 modulates plasma cholesterol and c-reactive protein concentrations in nonagenarians. J Am Geriatr Soc. 2005;53:1552-1558.
13. Straub RH, Cutolo M, Zietz B, Scholmerich J. the process of aging changes the interplay of the immune, endocrine and nervous systems. Mech Ageing Dev. 2001;122:1591-1611.
14. Lagrand WK, Visser CA, Hermens WT, et al. c-reactive protein as a cardiovascular risk factor: more than an epiphenomenon? Circulation. 1999;100:96-102.
15. de Ferranti SD, Rifai N. c-reactive protein: a nontraditional serum marker of cardiovascular risk. Cardiovasc Pathol. 2007;16:14-21
16. Roubenoff R. catabolism of aging: is it an infammatory process? Curr Opin Clin Nutr Metab Care. 2003;6:295-299.
17. Roubenoff R, Parise H, Payette HA, et al. cytokineS, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study. Am J Med. 2003;115:429-435. (Pubitemid 37237554)
18. Jylha M, Paavilainen P, lehtimaki T, et al. interleukin-1 receptor antagonist, interleukin-6, and c-reactive protein as predictors of mortality in nonagenarians: the vitality 90+ study. J Gerontol A Biol Sci Med Sci. 2007;62:1016-1021.
19. Harris TB, Ferrucci L, Tracy RP, et al. associations of elevated inter-leukin-6 and c-reactive protein levels with mortality in the elderly. Am J Med. 1999;106:506-512.
20. Bruunsgaard H, Ladelund S, Pedersen AN, Schroll M, Jorgensen T, Pedersen BK. Predicting death from tumour necrosis factor-alpha and interleukin-6 in 80-year-old people. Clin Exp Immunol. 2003;132: 24-31.
21. Ferrucci L, Cavazzini C, Corsi A, et al. Biomarkers of frailty in older persons. J Endocrinol Invest. 2002;25(10 suppl):10-15.
22. McDermott MM, Greenland P, Guralnik JM, et al. infammatory markerS, D-dimer, pro-thrombotic factorS, and physical activity levels in patients with peripheral arterial disease. Vasc Med. 2004;9: 107-115.
23. Brinkley TE, leng X, Miller ME, et al. chronic infammation is associated with low physical function in older adults across multiple comorbidities. J Gerontol A Biol Sci Med Sci. 2009;64:455-461.
24. Figaro MK, Kritchevsky SB, Resnick HE, et al. DiabeteS, infamma-tioN, and functional decline in older adults: fndings from the Health, aging and Body composition (aBc) study. Diabetes Care. 2006;29: 2039-2045.
25. Visser M, Pahor M, Taaffe DR, et al. Relationship of interleukin-6 and tumor necrosis factor-alpha with muscle mass and muscle strength in elderly men and women: the Health aBc Study. J Gerontol A Biol Sci Med Sci. 2002;57:M326-32.
26. Yende S, Waterer GW, Tolley EA, et al. infammatory markers are associated with ventilatory limitation and muscle dysfunction in obstructive lung disease in well functioning elderly subjects. Thorax. 2006;61:10-16.
27. Schaap LA, Pluijm SM, Deeg DJ, Visser M. infammatory markers and loss of muscle mass (sarcopenia) and strength. Am J Med. 2006;119:526.e9-526.e17.
28. Penninx BW, Kritchevsky SB, Newman AB, et al. infammatory markers and incident mobility limitation in the elderly. J Am Geriatr Soc. 2004;52:1105-1113.
29. Taaffe DR, Harris TB, Ferrucci L, Rowe J, Seeman TE. cross-sectional and prospective relationships of interleukin-6 and c-reactive protein with physical performance in elderly persons: Macarthur studies of successful aging. J Gerontol A Biol Sci Med Sci. 2000;55: M709-M715.
30. Cesari M, Penninx BW, Pahor M, et al. infammatory markers and physical performance in older persons: the incHianti study. J Gerontol A Biol Sci Med Sci. 2004;59:242-248.
31. Jylha M, Hervonen A. Functional status and need of help among people aged 90 or over: a mailed survey with a total home-dwelling population. Scand J Public Health. 1999;27:106-111.
32. Skelton DA, Greig CA, Davies JM, Young A. Strength, power and related functional ability of healthy people aged 65-89 years. Age Ageing. 1994;23:371-377.
33. Mahoney FI, Barthel DW. Functional evaluation: the Barthel index. Md State Med J. 1965;14:61-65.
34. Sainsbury A, Seebass G, Bansal A, Young JB. Reliability of the Barthel index when used with older people. Age Ageing. 2005;34:228-232.
35. Hamer M, Molloy GJ. association of c-reactive protein and muscle strength in the English longitudinal Study of ageing. Age. 2009;31: 171-177.
36. Kritchevsky SB, Cesari M, Pahor M. infammatory markers and cardiovascular health in older adults. Cardiovasc Res. 2005;66:265-275.